Perspective Therapeutics (CATX) EBT (2010 - 2026)
Perspective Therapeutics (CATX) posted EBT of -$28.9 million for Q1 2026, up 24.44% sequentially from -$38.3 million in Q4 2025, and down 59.13% YoY from -$70.8 million in Q1 2025.
Perspective Therapeutics (CATX) EBT (2010 - 2026) Analysis & Trends
Perspective Therapeutics has reported EBT for 17 years, with the latest figure at -$28.9 million in Q1 2026.
- Quarterly EBT fell 59.13% year-over-year to -$28.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$115.2 million (down 33.4% YoY) and the FY2025 annual result came in at -$104.4 million, down 30.55% from the prior year.
- EBT grew to -$28.9 million in Q1 2026 per CATX's latest filing, from -$38.3 million in the prior quarter.
- Over five years, EBT peaked at -$1.3 million in Q1 2022 and troughed at -$41.8 million in Q4 2024.
- A 5-year average of -$15.9 million and a median of -$11.2 million in 2024 frame the typical range for EBT.
- The widest YoY moves for EBT: up 56.96% in 2022, down 1046.13% in 2022.
- Over 5 years, EBT stood at -$7.3 million in 2022, then retreated by 5.97% to -$7.8 million in 2023, then sank by 438.12% to -$41.8 million in 2024, then climbed by 8.48% to -$38.3 million in 2025, then grew by 24.44% to -$28.9 million in 2026.
- According to Business Quant data, EBT over the past three periods registered -$28.9 million, -$38.3 million, and -$26.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 1.52 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.56 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.83 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 1.06 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 519.80 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 317.50 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 693.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 855.50 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 273.50 Mn |
| 10 | Perspective Therapeutics | 389.10 Mn | 389.10 Mn | - | -26.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -26.98 Mn |
| Mar 31, 2026 | -28.93 Mn |
| Dec 31, 2025 | -38.28 Mn |
| Sep 30, 2025 | -25.97 Mn |
| Jun 30, 2025 | -22.00 Mn |
| Mar 31, 2025 | -18.18 Mn |
| Dec 31, 2024 | -41.83 Mn |
| Sep 30, 2024 | -15.12 Mn |
| Jun 30, 2024 | -11.21 Mn |
| Mar 31, 2024 | -11.83 Mn |
| Dec 31, 2023 | -7.77 Mn |
| Sep 30, 2023 | -9.57 Mn |
| Jun 30, 2023 | -9.49 Mn |
| Mar 31, 2023 | -10.87 Mn |
| Dec 31, 2022 | -7.34 Mn |
| Sep 30, 2022 | -7.49 Mn |
| Jun 30, 2022 | -3.43 Mn |
| Mar 31, 2022 | -1.35 Mn |
| Dec 31, 2021 | -1.60 Mn |
| Sep 30, 2021 | -2.59 Mn |